Kevin Borth

Kevin Borth has over 30 years of experience in sales and executive positions within the pharmaceutical industry. Kevin started their career at Sanofi in 1988 and worked in various sales roles, specializing in hospital, radiology, cardiac surgery, rheumatology, cardiology, neurology, and anesthesiology. Kevin successfully launched and managed several billion-dollar brands during their time at Sanofi. Kevin also worked at Sanofi-Synthelabo and Roche before joining Amylin Pharmaceuticals as the Director of National Accounts-Managed Markets in 2005. Kevin later transitioned to a role as a Strategic Accounts Manager at Eisai in 2010. Following this, they served as a Senior National Account Manager at ACADIA Pharmaceuticals Inc. in 2015. Kevin then worked as a Senior National Account Executive at Bristol-Myers Squibb/Celgene from 2015 to 2021. After that, they served as a Senior National Account Executive at ADC Therapeutics until 2023, when they started their current role as the Senior Director of Payer and Strategic Accounts at Day One Biopharmaceuticals. Throughout their career, Kevin has been recognized as a multiple award-winning sales professional with expertise in managing diverse portfolios of products.

Kevin Borth pursued their education in a chronological manner, beginning in 1980. Kevin attended Canisius University for four years, obtaining a Bachelor's degree in International Business, International Relations, and German. In 2006, Kevin enrolled in the Executive Certificate Course Work at Northwestern University's Kellogg School of Management, focusing on Business Negotiations and Management.